Marcus A. Carden

594 total citations
20 papers, 297 citations indexed

About

Marcus A. Carden is a scholar working on Genetics, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marcus A. Carden has authored 20 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 9 papers in Hematology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marcus A. Carden's work include Hemoglobinopathies and Related Disorders (13 papers), Iron Metabolism and Disorders (7 papers) and Erythrocyte Function and Pathophysiology (5 papers). Marcus A. Carden is often cited by papers focused on Hemoglobinopathies and Related Disorders (13 papers), Iron Metabolism and Disorders (7 papers) and Erythrocyte Function and Pathophysiology (5 papers). Marcus A. Carden collaborates with scholars based in United States, Russia and Hungary. Marcus A. Carden's co-authors include Jane A. Little, Meredith E. Fay, Wilbur A. Lam, Yumiko Sakurai, Jordan C. Ciciliano, Ross M. Fasano, Robert G. Mannino, Emily Riehm Meier, Clinton H. Joiner and David R. Myers and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Marcus A. Carden

19 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcus A. Carden United States 8 169 155 59 45 40 20 297
Martin Mukisi-Mukaza Guadeloupe 9 69 0.4× 134 0.9× 47 0.8× 42 0.9× 7 0.2× 9 331
Haley Newman United States 8 47 0.3× 41 0.3× 13 0.2× 20 0.4× 28 0.7× 20 253
Shanda Robertson United States 7 212 1.3× 284 1.8× 17 0.3× 27 0.6× 12 0.3× 10 407
Alberta Alghisi Italy 9 42 0.2× 91 0.6× 7 0.1× 27 0.6× 17 0.4× 13 252
Eva M. de Wee Netherlands 9 361 2.1× 76 0.5× 4 0.1× 22 0.5× 31 0.8× 10 432
Özlem Bostan Türkiye 12 24 0.1× 18 0.1× 20 0.3× 112 2.5× 12 0.3× 48 336
Emilce E. Schneeberger Argentina 11 97 0.6× 9 0.1× 11 0.2× 21 0.5× 28 0.7× 47 379
R. Michl Germany 11 50 0.3× 36 0.2× 26 0.4× 251 5.6× 6 0.1× 16 352
Valentin Lacombe France 10 30 0.2× 40 0.3× 37 0.6× 8 0.2× 3 0.1× 26 219
M. Richardson Australia 8 23 0.1× 30 0.2× 13 0.2× 125 2.8× 14 0.3× 12 295

Countries citing papers authored by Marcus A. Carden

Since Specialization
Citations

This map shows the geographic impact of Marcus A. Carden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus A. Carden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus A. Carden more than expected).

Fields of papers citing papers by Marcus A. Carden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus A. Carden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus A. Carden. The network helps show where Marcus A. Carden may publish in the future.

Co-authorship network of co-authors of Marcus A. Carden

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus A. Carden. A scholar is included among the top collaborators of Marcus A. Carden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus A. Carden. Marcus A. Carden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilson, Samuel, et al.. (2024). Adolescents and young adults with sickle cell disease exhibit accelerated aging with elevated T-cell p16INK4a expression. Aging. 16(21). 13225–13236. 1 indexed citations
2.
Hardy, Elaissa T., et al.. (2022). Building the foundation of health‐related knowledge via near‐peer education for children with sickle cell disease. Pediatric Blood & Cancer. 69(4). e29566–e29566. 1 indexed citations
3.
Wilson, Samuel, Marcella H. Boynton, Marcus A. Carden, et al.. (2021). Age-Associated Decline in Blood Parameters in Individuals with Sickle Cell Disease. Blood. 138(Supplement 1). 970–970. 1 indexed citations
4.
Carden, Marcus A., Manila Gaddh, Michael Brown, et al.. (2020). Rituximab leads to early elimination of circulating CD20+ T and B lymphocytes in patients with iTTP despite ongoing TPEx. Blood Advances. 4(3). 477–481. 6 indexed citations
5.
Wright, Frances, et al.. (2020). Hemoglobin A1c and fructosamine correlate in a patient with sickle cell disease and diabetes on chronic transfusion therapy. Pediatric Blood & Cancer. 67(9). e28499–e28499. 3 indexed citations
6.
7.
Carden, Marcus A., Ross M. Fasano, & Emily Riehm Meier. (2019). Not all red cells sickle the same: Contributions of the reticulocyte to disease pathology in sickle cell anemia. Blood Reviews. 40. 100637–100637. 22 indexed citations
8.
Carden, Marcus A. & Jane A. Little. (2019). Emerging disease-modifying therapies for sickle cell disease. Haematologica. 104(9). 1710–1719. 68 indexed citations
9.
Carden, Marcus A., Paula Tanabe, & Jeffrey Glassberg. (2019). Intravenous Fluid Boluses Are Commonly Administered to Adults with Sickle Cell Disease and Vaso-Occlusive Pain. Blood. 134(Supplement_1). 4839–4839. 2 indexed citations
10.
Caruso, Christina, Yumiko Sakurai, Meredith E. Fay, et al.. (2019). Stiff Erythrocyte Subpopulations Biomechanically Induce Endothelial Inflammation in Sickle Cell Disease. Blood. 134(Supplement_1). 3560–3560. 5 indexed citations
11.
Maier, Cheryl L., Satheesh Chonat, Andrés Chang, et al.. (2019). Challenges in the treatment and prevention of delayed hemolytic transfusion reactions with hyperhemolysis in sickle cell disease patients. Transfusion. 59(5). 1698–1705. 17 indexed citations
12.
Wilson, Samuel, Frances Wright, & Marcus A. Carden. (2019). L-Glutamine Decreases Opioid Use in Individuals with Sickle Cell Disease and Chronic Pain: A Case Series. Blood. 134(Supplement_1). 4849–4849. 4 indexed citations
13.
Sakurai, Yumiko, Elaissa T. Hardy, Byungwook Ahn, et al.. (2018). A microengineered vascularized bleeding model that integrates the principal components of hemostasis. Nature Communications. 9(1). 509–509. 77 indexed citations
14.
Carden, Marcus A., Stephen D. Smith, Holly J. Meany, et al.. (2017). Platinum plus bortezomib for the treatment of pediatric renal medullary carcinoma: Two cases. Pediatric Blood & Cancer. 64(7). e26402–e26402. 7 indexed citations
15.
Carden, Marcus A., Meredith E. Fay, Yumiko Sakurai, et al.. (2017). Normal saline is associated with increased sickle red cell stiffness and prolonged transit times in a microfluidic model of the capillary system. Microcirculation. 24(5). 18 indexed citations
16.
Carden, Marcus A., Meredith E. Fay, Robert G. Mannino, et al.. (2017). Extracellular fluid tonicity impacts sickle red blood cell deformability and adhesion. Blood. 130(24). 2654–2663. 39 indexed citations
17.
Carden, Marcus A., et al.. (2016). Health literacy and disease-specific knowledge of caregivers for children with sickle cell disease. Pediatric Hematology and Oncology. 33(2). 121–133. 20 indexed citations
18.
19.
Carden, Marcus A., et al.. (2012). Pulmonary Alveolar Proteinosis in Association with Congenital Dyserythropoietic Anemia: A Case Report. SHILAP Revista de lepidopterología. 2012. 1–3. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026